| Basics |
LeMaitre Vascular, Inc.
LeMaitre Vascular Inc provides medical devices and human tissue cryopreservation services for the treatment of peripheral vascular disease. The company develops, manufactures, and markets vascular devices to address the needs of vascular surgeons.
|
| IPO Date: |
October 19, 2006 |
| Sector: |
Healthcare |
| Industry: |
Health Care Equipment and Supplies |
| Market Cap: |
$1.92B |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.42 | 1.86%
|
| Avg Daily Range (30 D): |
$1.14 | 1.32%
|
| Avg Daily Range (90 D): |
$1.12 | 1.25%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.07M |
| Avg Daily Volume (30 D): |
.12M |
| Avg Daily Volume (90 D): |
.12M |
| Trade Size |
| Avg Trade Size (Sh.): |
64 |
| Avg Trade Size (Sh.) (30 D): |
31 |
| Avg Trade Size (Sh.) (90 D): |
32 |
| Institutional Trades |
| Total Inst.Trades: |
1,604 |
| Avg Inst. Trade: |
$1.59M |
| Avg Inst. Trade (30 D): |
$2.14M |
| Avg Inst. Trade (90 D): |
$2.42M |
| Avg Inst. Trade Volume: |
.03M |
| Avg Inst. Trades (Per Day): |
1 |
| Market Closing Trades |
| Avg Closing Trade: |
$1.62M |
| Avg Closing Trade (30 D): |
$2.33M |
| Avg Closing Trade (90 D): |
$2.54M |
| Avg Closing Volume: |
26.97K |
|
|
| Financials |
| |
TTM |
Q3 2025 |
Q2 2025 |
|
Basic EPS
|
|
$.77
|
$.61
|
|
Diluted EPS
|
|
$.75
|
$.6
|
|
Revenue
|
$
|
$ 61.05M
|
$ 64.23M
|
|
Gross Profit
|
$
|
$ 45.96M
|
$ 44.97M
|
|
Net Income / Loss
|
$
|
$ 17.36M
|
$ 13.78M
|
|
Operating Income / Loss
|
$
|
$ 20.31M
|
$ 16.14M
|
|
Cost of Revenue
|
$
|
$ 15.09M
|
$ 19.26M
|
|
Net Cash Flow
|
$
|
$ -1.63M
|
$ 1.18M
|
|
PE Ratio
|
|
|
|
|
|
|
